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The cellular identity of niche cells that regulate hematopoietic stem cell (HSC) self-renewal and differentiation
has been debated for several years. Two recent studies inNature (Ding andMorrison, 2013; Greenbaumet al.,
2013) have shed light into the bone marrow stromal subsets making CXCL12, a chemokine critical for HSC
maintenance.The identification of niche cells in the
bone marrow has been fraught with diffi-
culties due, for instance, to the encase-
ment of the marrow in bone, by the
paucity of specific markers to separate
stromal cells, and by the infidelity of
some genetic markers for mesenchymal
lineages. Because of these challenges,
there have been conflicting reports on
the cellular identity of the hematopoietic
stem cell (HSC) niche. For example, prior
studies have suggested that the endos-
teal region, populated by osteoblasts,
was a niche maintaining quiescent
HSCs, whereas other studies have sug-
gested that most HSCs are found near
blood vessels (reviewed in Mercier et al.,
2012; Frenette et al., 2013).
A hallmark of a putative stromal cell
niche candidate is the regulated expres-
sion of specific factors mediating HSC
maintenance. Among these factors is
stromal cell-derived factor-1 (SDF1, now
called CXCL12), a chemokine essential
for maintaining HSCs in adult bone
marrow (Tzeng et al., 2011). CXCL12-
abundant reticular (CAR) cells, marked
by green fluorescent protein (GFP)
expression inserted in the Cxcl12 locus,
are largely perivascular cells, whereas
endothelial cells and bone-lining osteo-
blasts express lower levels of GFP
(reviewed in Sugiyama and Nagasawa,
2012). Ablation of CAR cells leads to a
reduction in the frequency of HSCs, as
well as lymphoid and erythroid progeni-
tors. However, the identity and composi-
tion of CAR cells and their contributions
as niche cells have been unclear.
In a recent issue of Nature, two com-
panion papers from the laboratories of
Drs. Sean Morrison and Daniel Link have
applied an elegant approach by condi-tional deletion of Cxcl12 in various candi-
date niche cells (Ding andMorrison, 2013;
Greenbaum et al., 2013). This approach
allows them to evaluate the functional
impact of CXCL12 synthesis by different
niche components and to define distinct
specialized niches for HSC maintenance,
HSC retention, and the generation of
certain lymphoid progenitors.
Deletion of Cxcl12 in osteoblasts using
Col2.3-cre mice reveals no alteration in
HSC or myeloerythroid progenitor cell
numbers. However, these mice show
significantly lower levels of T cell and
B cell reconstitution and fewer early
lymphoid progenitors in the bone marrow
(Figure 1). These findings are consistent
with the accumulation of early lymphoid
progenitors adjacent to the endosteum
(Ding and Morrison, 2013). In the article
by Link and colleagues (Greenbaum
et al., 2013), the contribution of osteoline-
age cells is further dissected by Cxcl12
deletion in mature osteoblasts (using
Osteocalcin-cre transgenics) or in osteo-
progenitors (using Osterix-cre). The au-
thors also find that CXCL12 from mature
osteoblasts, aswell as osteoblast progen-
itors, is dispensable forHSCmaintenance.
However, conditional deletion of Cxcl12
in osteoprogenitors leads to mobilization
of hematopoietic progenitor cells to the
blood and spleen. Deletion of Cxcl12 in
osteoprogenitors, but not inmature osteo-
blasts, reduces the number of B lymphoid
progenitors, which is consistent with re-
sults following the deletion of CAR cells
and supports a role for osteoprogenitors
or/and CAR cells in B lymphoid commit-
ment (Omatsu et al., 2010).
Endothelial cell-specific Cxcl12 dele-
tion can be achieved using Tie2-cre
mice, which reveal that endothelial cellsCell Stem Cesynthesize a relatively modest amount of
CXCL12 compared to other stromal cells.
Consequently, modest defects in HSC
numbers and competitive reconstitution
activities are observed in these mice
(Ding and Morrison, 2013; Greenbaum
et al., 2013). No reductions in committed
myeloid or lymphoid progenitors were
documented, suggesting a restricted
contribution of endothelial cell-derived
CXCL12 to HSC maintenance (Figure 1).
Previous studies have shown that puta-
tive niche cells for HSC maintenance are
marked by Nestin, an intermediate fila-
ment protein found in self-renewing
mesenchymal stem cells (MSCs)(Frenette
et al., 2013). In transgenic GFP reporter
mice, Nes-GFP+ cells express very high
levels of CXCL12 and contain all MSC ac-
tivity in the bone marrow (Me´ndez-Ferrer
et al., 2010). Because Nestin was first re-
ported as a marker for neuroectoderm
progenitors, transgenic reporters have
thus far been generated and screened to
label neural progenitors, and, conse-
quently, expression in the bone marrow
is variable and depends on the transgenic
strain. Ding and Morrison reported,
surprisingly, no effect of Nes-cre on
CXCL12 and HSC frequencies and
numbers, suggesting that loxP recombi-
nation most likely did not occur in Nes-
GFP+ cells. In order to delete Cxcl12 in
multipotent mesenchymal progenitors,
both companion studies used the Prx1-
cre transgenic mice in which cre was
driven by a transcription factor promoter
expressed during limb bud mesoderm
development. This model induces recom-
bination in osteoblasts and the majority of
PDGFRa+ stromal cells, but not in endo-
thelial cells. In both studies, the authors
observe a dramatic reduction in bonell 12, April 4, 2013 ª2013 Elsevier Inc. 391
Figure 1. Distinct Cellular Sources and Niches for CXCL12 in Bone
Marrow
Most CXCL12 is derived from perivascular stromal cells that can bemarked by
Prx1-cre, Lepr-cre, or Nestin-Gfp that likely show significant overlap with each
other. The highest levels of CXCL12 are secreted by the most immature
mesenchymal stem/progenitor cells (MSPC). Osteoblasts, marked by Osteo-
calcin (Oc), synthesize low amounts of CXCL12 that are not essential for
normal hematopoiesis, whereas deletion of Cxcl12 in osteoblasts using
Col2.3-cre leads to deficits in certain early lymphoid progenitors similar to Os-
terix-cre, suggesting a contribution of osteoprogenitors in the generation of
lymphoid precursors. Endothelial cells, marked by Tie2-cre, also secrete
CXCL12 and contribute to HSC maintenance. Although some hematopoietic
cells express CXCL12, deletion in the hematopoietic system using Vav1-cre
did not yield any phenotype. The effect of Prx1-targeted cells on lymphoid pro-
genitors is indicated with a dashed line because it is likely to be derived from
osteoprogenitors or perivascular stromal Prx1-cre-targeted cell fraction. The
size of circles does not reflect the actual frequencies in the bone marrow,
and the overlap among different models is based on estimations. HSC, he-
matopoietic stem cell; HPC, hematopoietic progenitor cell; CLP, common
lymphoid progenitor; LMMP, lymphoid-primed multipotent progenitor.
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Previewsmarrow HSCs and increased
splenic HSCs, suggesting a
substantial contribution of
CXCL12 derived from peri-
vascular stromal cells in
HSC maintenance and reten-
tion in the bone marrow.
Deletion of Cxcl12 in Prx1-
cre-recombined cells also
leads to reduced lymphoid
progenitors, which reinforces
the aforementioned contribu-
tion of osteolineage cells to
the generation of early
lymphoid progenitors.
Leptin receptor (Lepr)-
driven cre leads to recombi-
nation in perivascular sinusoi-
dal stromal cells that express
high levels of stem cell factor
(SCF), which was previously
reported to be essential for
HSCmaintenance (Dinget al.,
2012). Deletion of Cxcl12
by Lepr-cre significantly re-
duces Cxcl12 expression
within the sinusoidal stromal
compartment but does not
alter HSC and progenitor
numbers in the bone marrow.
However, it induces themobi-
lization of HSCs and progeni-
tors to spleen and peripheral
blood. These studies suggest
a role for CXCL12 derivedfrom Lepr-marked cells specifically in
HSC retention rather than maintenance.
Given that both SCF and CXCL12 expres-
sion in bone marrow are required to
maintain HSCs, and that SCF- and
CXCL12-expressing stromal cells greatly
(>94%) overlap (Ding and Morrison,
2013), the phenotypic difference with re-
gard to HSC maintenance between Lepr-
cre;ScfD/D and Lepr-cre;Cxcl12D/D mice
is puzzling. Hence, the dramatic defect in
HSC maintenance observed in the Prx1-
cre;Cxcl12D/Dmodel must arise from con-
tributions of a nonendothelial Lepr-nega-
tive stromal cell.
To further investigate the nature of
these cells, Greenbaum and colleagues
evaluated whether Prx1-cre targeted
PDGFRa+/Sca-1+ (PaS) cells, which
have been suggested to comprise bone
marrow MSCs (Morikawa et al., 2009).
They found that Prx1-cre indeed targets
50% of PaS cells, whereas Osterix-cre
does not, which is consistent with the392 Cell Stem Cell 12, April 4, 2013 ª2013 Elidea that Prx1-cre induce recombination
in MSC-like cells. Furthermore, all col-
ony-forming unit fibroblast (CFU-F) activ-
ity appears to be derived from Prx1-cre-
targeted PaS cells that do not express
Nestin. In fact, the frequency of CFU-F,
a hallmark of MSCs, in Prx1-cre-targeted
PaS cells is much greater than that re-
ported for Nes-GFP+ cells, suggesting
that Prx1-cre indeed targets mesen-
chymal progenitors (Greenbaum et al.,
2013). However, it is important to note
that comparisons of Prx1-cre-targeted
PaS cells with other studies are prevented
bymeaningful (and underappreciated) dif-
ferences in the methods of bone marrow
harvest. For example, all MSC activity
can be recovered from Nes-GFP+ cells
when flushing the bone marrow core, a
method that excludes bone stromal cells
from the analysis (Me´ndez-Ferrer et al.,
2010). Greenbaum and colleagues used
a bone crushingmethod that incorporates
bone stromal cells that exhibit muchsevier Inc.higher CFU-F content and
are likely to be phenotypically
and functionally different
from those found in the bone
marrow. Although further
studies are needed to charac-
terize these MSCs, it is likely
that Prx1-cre also targets
bone marrow Nes-GFP+ cells.
Overall, these two excellent
papers are consistent with the
idea that HSC maintenance
and self-renewal are provided
by an immature mesenchymal
stem and progenitor (i.e.,
MSC) and show that the reten-
tion of HSCs and progenitors
in bone marrow is provided
by a distinct stromal niche
marked by Lepr and Osterix.
By identifying osteoproge-
nitor cells as a possible
stromal constituent gener-
ating certain lymphoid precur-
sors, these papers pave the
way toward a systematic
effort to match differentiated
stromal niche subsets with
their differentiating hemato-
poietic counterparts.
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